Zhejiang Shapuaisi Pharmaceutical Co Ltd (603168) — Net Asset Momentum
Zhejiang Shapuaisi Pharmaceutical Co Ltd (603168) recorded a net asset momentum of -8.1% as of December 2024, with net assets of CN¥1.59 Billion CNY. Net Asset Momentum measures the year-over-year percentage change in net assets (total assets minus total liabilities), indicating how rapidly the company is building or eroding its equity base. See shareholders equity of Zhejiang Shapuaisi Pharmaceutical Co Ltd for net asset value and shareholders' equity analysis.
YoY Momentum
Current Net Assets
Years of Data
Country
Zhejiang Shapuaisi Pharmaceutical Co Ltd Net Asset Momentum (2008–2024)
This chart tracks Zhejiang Shapuaisi Pharmaceutical Co Ltd's year-over-year net asset growth across 17 annual reporting periods from 2008 to 2024. The most recent momentum reading is -8.1%, with net assets of CN¥1.59 Billion CNY as of December 2024. For live market cap and overall valuation, see 603168 market cap.
Annual Net Asset History for Zhejiang Shapuaisi Pharmaceutical Co Ltd (2008–2024)
The table below shows the complete annual net asset history for Zhejiang Shapuaisi Pharmaceutical Co Ltd from 2008 to 2024, covering 17 yearly periods. Each row includes total assets, total liabilities, net assets, and the year-over-year momentum figure for that period. Check 603168 tangible net assets ratio to evaluate the tangible quality of the company's equity base.
| Year | Net Assets (CNY) | Total Assets | Total Liabilities | YoY Momentum |
|---|---|---|---|---|
| 2024 | CN¥1.59 Billion | CN¥2.11 Billion | CN¥516.59 Million | ▼ -8.1% |
| 2023 | CN¥1.73 Billion | CN¥2.17 Billion | CN¥440.92 Million | ▲ +0.7% |
| 2022 | CN¥1.72 Billion | CN¥1.96 Billion | CN¥240.99 Million | ▲ +26.9% |
| 2021 | CN¥1.35 Billion | CN¥1.59 Billion | CN¥232.89 Million | ▲ +3.5% |
| 2020 | CN¥1.31 Billion | CN¥1.67 Billion | CN¥366.78 Million | ▼ -12.3% |
| 2019 | CN¥1.49 Billion | CN¥1.59 Billion | CN¥100.28 Million | ▲ +0.5% |
| 2018 | CN¥1.48 Billion | CN¥1.65 Billion | CN¥167.41 Million | ▼ -10.6% |
| 2017 | CN¥1.66 Billion | CN¥1.87 Billion | CN¥212.13 Million | ▲ +4.0% |
| 2016 | CN¥1.59 Billion | CN¥1.84 Billion | CN¥247.88 Million | ▲ +78.8% |
| 2015 | CN¥891.62 Million | CN¥1.27 Billion | CN¥383.37 Million | ▲ +16.9% |
| 2014 | CN¥762.90 Million | CN¥872.34 Million | CN¥109.44 Million | ▲ +115.9% |
| 2013 | CN¥353.31 Million | CN¥597.57 Million | CN¥244.26 Million | ▲ +28.8% |
| 2012 | CN¥274.21 Million | CN¥516.54 Million | CN¥242.33 Million | ▲ +35.8% |
| 2011 | CN¥201.95 Million | CN¥327.38 Million | CN¥125.43 Million | ▲ +32.8% |
| 2010 | CN¥152.04 Million | CN¥222.49 Million | CN¥70.45 Million | ▲ +38.6% |
| 2009 | CN¥109.67 Million | CN¥186.82 Million | CN¥77.15 Million | ▲ +17.2% |
| 2008 | CN¥93.58 Million | CN¥162.82 Million | CN¥69.24 Million | — |